SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000950137-05-004271
Filing Date
2005-04-11
Accepted
2005-04-08 18:17:37
Documents
4
Period of Report
2005-05-19
Effectiveness Date
2005-04-11

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT a07368ddef14a.htm DEF 14A 492249
2 GRAPHIC a07368da0736800.gif GRAPHIC 1174
3 GRAPHIC a07368da0736801.gif GRAPHIC 2902
4 GRAPHIC a07368da0736802.gif GRAPHIC 12772
  Complete submission text file 0000950137-05-004271.txt   511016
Mailing Address 6455 NANCY RIDGE DR SAN DIEGO CA 92121
Business Address 6455 NANCY RIDGE DR SAN DIEGO CA 92121 8584526600
LA JOLLA PHARMACEUTICAL CO (Filer) CIK: 0000920465 (see all company filings)

IRS No.: 330361285 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-24274 | Film No.: 05742522
SIC: 2836 Biological Products, (No Diagnostic Substances)